Lymphokine-activated killer cell therapy combined with high-dose glucocorticoid showed clinical efficacy towards advanced lung carcinoma.

Abstract:

:We describe the case of a patient with terminal adenocarcinoma of the lung with no response to lymphokine-activated killer (LAK) cell therapy alone who distinctly responded clinically to a combination of high-dose glucocorticoids (GC) and LAK cell therapy, administered by chance. However, after decreasing the dose of GC because of gastrointestinal bleeding caused by the high-dose treatment, there was no response on restarting GC plus LAK cell therapy. The clinical course of this case strongly suggests that local inflammation in the vicinity of tumors should be adequately suppressed in patients with advanced cancer who receive immunotherapy.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Kato M,Goto S,Soma G

subject

Has Abstract

pub_date

2010-08-01 00:00:00

pages

3125-8

issue

8

eissn

0250-7005

issn

1791-7530

pii

30/8/3125

journal_volume

30

pub_type

杂志文章
  • Molecular mechanisms involved in DNA repair, in gene rearrangement and in gene amplification may be considered as an integrated system in maintaining cellular homeostasis and cell survival.

    abstract::In procaryotic and also in eucaryotic cells, several systems for repairing the DNA damage have been discovered. The mechanism and genetic control of DNA excision-repair and SOS have been extensively studied. These repair processes help prevent lesions from interfering with DNA functions or from converting into permane...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Tonini GP

    更新日期:1988-09-01 00:00:00

  • Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.

    abstract:BACKGROUND/AIM:To identify predictors of local control and survival after whole-brain irradiation (WBI) for cerebral metastases from cancer of unknown primary (CUP). PATIENTS AND METHODS:In 140 patients receiving WBI alone or following resection, seven factors were investigated including treatment approach, WBI-regime...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12492

    authors: Rades D,Dziggel L,Janssen S,Khoa MT,Duong VN,Khiem VH,Gebauer N,Bartscht T,Schild SE

    更新日期:2018-04-01 00:00:00

  • Antitumor metallocenes: new developments and toxicologic features.

    abstract::Recent results concerning new antitumor metallocene derivatives have shown that not only numerous titanocene dihalides and bis(pseudohalides) exhibit antiproliferative activity, but that also some titanocene complexes (C5H5)2TiX2 containing carboxylates or hydrochlorinated aminothiophenolates as ligands X, are charact...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Köpf-Maier P,Köpf H

    更新日期:1986-03-01 00:00:00

  • Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma.

    abstract::An examination of eighteen thiols and thio ethers revealed that the simultaneous administration of several of these with cis-platinum (CDDP) at 7.5 mg/kg (25 mumols/kg) iv, as a single injection to rats bearing the Walker 256 carcinosarcoma led to significant reduction in the nephrotoxicity typically found with cis-pl...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Jones MM,Basinger MA

    更新日期:1989-11-01 00:00:00

  • Yeast-derived beta-(1-3),(1-6)-D-glucan induces up-regulation of CD86 on dectin-1-positive human B-lymphoma cell lines.

    abstract:BACKGROUND:The knowledge of direct effects of β-glucans on tumor cells is limited. This study evaluated the impact of a soluble yeast-derived beta-(1-3),(1-6)-d-glucan, containing a fraction of aggregated sugar polymers, on viability, proliferation and expression of CD86 of the human B-cell lymphoma cell lines Daudi an...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Harnack U,Kellermann U,Pecher G

    更新日期:2011-12-01 00:00:00

  • Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines.

    abstract:BACKGROUND:The constant overexpression of glycolysis and active mitochondrial function are critical for productive energy required for the immortal proliferation of cancer cells. The genes related to glycolysis and mitochondrial respiration might have some function during stomach carcinogenesis. MATERIALS AND METHODS:...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rho M,Kim J,Jee CD,Lee YM,Lee HE,Kim MA,Lee HS,Kim WH

    更新日期:2007-01-01 00:00:00

  • Evaluation of Stem Cell Marker Expression in Canine B-Cell Lymphoma Cell Lines, B-Cell Lymphoma-generated Spheres and Primary Samples.

    abstract:BACKGROUND:Canine lymphoma has lately drawn focus as a model of human non-Hodgkin's lymphoma due to its spontaneous occurrence and similar biological behavior. Cells with stem cell-like characteristics are believed to play a key role in therapeutic failure. Thus, an initial characterization and the possibility of speci...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liu W,Selçuk F,Rütgen BC,Moulay M,Willenbrock S,Hammer SE,Sterenczak KA,Junghanss C,Hewicker-Trautwein M,Nolte I,Murua Escobar H

    更新日期:2015-05-01 00:00:00

  • Unexpected toxicity after low-dose docetaxel treatment of a cancer patient with clinically latent HCV-positive hepatic cirrhosis.

    abstract::We report a case with unexpected toxicity after low-dose docetaxel chemotherapy. The patient had a history of clinically latent HCV-positive hepatic cirrhosis when she presented with inoperable pulmonary adenocarcinoma. She was recruited in a protocol combining standard radiotherapy (RT) with docetaxel (30 mg/m2 week)...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Koukourakis MI,Kapsoritakis A,Maltezos E,Potamiano S,Mouzas I,Kouroumalis H

    更新日期:2002-07-01 00:00:00

  • Differences in breast carcinoma in situ between menopausal and premenopausal women.

    abstract:AIM:To seek differences between ductal carcinoma in situ (DCIS) according to the menopausal status of patients and to analyze their repercussions on patient care. PATIENTS AND METHODS:A multicenter retrospective study of 384 patients from 3 centers specialized in breast cancer surgery was carried out based on an analy...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Pradier C,Cornuau M,Norca J,Mesbah H,Poree P,Body G,Classe JM,Leveque J

    更新日期:2011-05-01 00:00:00

  • Characterization of amino acid transport system L in HTB-41 human salivary gland epidermoid carcinoma cells.

    abstract:BACKGROUND:The amino acid transport system L is a major nutrient transport system that is responsible for transport of neutral amino acids, including several essential amino acids. The current study attempted to investigate the expression and functional characterization of amino acid transport system L in HTB-41 human ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Park NS,Kim SG,Kim HK,Moon SY,Kim CS,Cho SH,Kanai Y,Endou H,Kim DK

    更新日期:2008-09-01 00:00:00

  • CYP2C9 polymorphisms in human tumors.

    abstract::The oxazaphosphorines cyclophosphamide (CP) and ifosfamide (IF) are alkylating agents that require bioactivation via cytochrome (CYP) P450 isoenzymes including CYP2C9 enzymes. The present study investigated CYP2C9 in regard to its allelic variants in 23 tumor samples (10 breast tumors, 1 breast tumor cell line, 5 brai...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Knüpfer H,Stanitz D,Preiss R

    更新日期:2006-01-01 00:00:00

  • Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimen.

    abstract:BACKGROUND:Paclitaxel pharmacokinetics were shown to be related to toxicity and survival. PATIENTS AND METHODS:We evaluated the effects of time above paclitaxel concentrations of 0.05 micromol/l (T(>0.05) and systemic exposures (AUC) to total and unbound paclitaxel (tPAC, uPAC) on response in patients with advanced ca...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Mielke S,Sparreboom A,Behringer D,Mross K

    更新日期:2005-11-01 00:00:00

  • An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres.

    abstract::Transcatheter embolization is considered to be less effective for early-stage hepatocellular carcinomas (HCCs) without a hypervascular arterial supply. In the present case report, a 65-year-old male with hepatitis type C and non-hypervascular HCC located in the hepatic hilum was successfully treated by bland transarte...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tanaka T,Maeda S,Nishiofuku H,Masada T,Sato T,Anai H,Sakaguchi H,Kichikawa K

    更新日期:2014-04-01 00:00:00

  • Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.

    abstract:BACKGROUND/AIM:The aim of this study was to analyze the pretreatment cytokeratin serum levels in head and neck squamous cell carcinoma (HNSCC) by three assays in relation to selected clinicopathological characteristics in an effort to find diagnostic/prognostic biomarkers for HNSCC and determine the best assay. PATIEN...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13713

    authors: Kalfert D,Ludvik J,Kucera R,Topolcan O,Celakovsky P,Pesta M,Kholova I,Plzak J,Ludvikova M

    更新日期:2019-09-01 00:00:00

  • Molecular Characterization of Second Primary Endometrial Cancer.

    abstract:BACKGROUND/AIM:The objective of this study was to determine the molecular and clinicopathological features, as well as the prognosis of patients with endometrial cancer (EC) having prior malignancy (second primary EC: SPEC) compared with those without a history of prior malignancy (first primary EC: FPEC). MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14370

    authors: Haraga J,Nakamura K,Haruma T,Nyuya A,Nagasaka T,Masuyama H

    更新日期:2020-07-01 00:00:00

  • Prognostic Significance of Solid and Micropapillary Components in Invasive Lung Adenocarcinomas Measuring ≤3 cm.

    abstract:BACKGROUND/AIM:We aimed to analyze the clinical impact of solid and micropapillary components in a series of Japanese patients resected for ≤3 cm lung adenocarcinoma. PATIENTS AND METHODS:A total of 115 patients with ≤3 cm lung adenocarcinomas were reviewed and classified according to the American Thoracic Society and...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11058

    authors: Matsuoka Y,Yurugi Y,Takagi Y,Wakahara M,Kubouchi Y,Sakabe T,Haruki T,Araki K,Taniguchi Y,Nakamura H,Umekita Y

    更新日期:2016-09-01 00:00:00

  • Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects.

    abstract:BACKGROUND:A double blind placebo RCT of adjuvant treatment of the matrix metalloproteinase inhibitor, Marimastat, in patients with unresectable colorectal liver metastases showed no significant effect on survival. There was a statistically significant survival advantage for the marimastat-treated patients with musculo...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: King J,Zhao J,Clingan P,Morris D

    更新日期:2003-01-01 00:00:00

  • The prognostic implication of clinical and histological features in Ph1+ chronic myelocytic leukaemia (CML).

    abstract::A study on clinical and histological features of prognostic significance was performed in 45 patients with Ph1+ -CML who showed median survival of 36 months. The histological features were evaluated by morphometry of iliac crest biopsies. Among the variables correlated with prognosis, we eliminated those without prima...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Thiele J,Fohlmeister I,Vonneguth B,Zankovich R,Fischer R

    更新日期:1986-11-01 00:00:00

  • Anti-tumor effect of novel cationic biomaterials in prostate cancer.

    abstract:BACKGROUND:Tumor cells expressing excessive anionic-charged sialic acid can be potentially targeted by cationic polymers which may inhibit tumor growth. In the present study, three new families of cationic polymers were synthesized to assess their effects on prostate cancer cells. MATERIALS AND METHODS:Cationic polyme...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gakhar G,Liu H,Shen R,Scherr D,Wu D,Nanus D,Chu CC

    更新日期:2014-08-01 00:00:00

  • 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.

    abstract:BACKGROUND:Natural killer (NK) cells are a third population of lymphocytes that can kill certain tumor cells. This killing is regulated by signals received through activating and inhibitory receptors. 2B4 (CD244), a member of the CD2 subset of Immunoglobulin superfamily, was identified as an activating receptor on NK c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Johnson LA,Vaidya SV,Goldfarb RH,Mathew PA

    更新日期:2003-09-01 00:00:00

  • Clinical outcomes after first-line EGFR inhibitor treatment for patients with NSCLC, EGFR mutation, and poor performance status.

    abstract:BACKGROUND:The phase II NEJ001 trial suggested that gefitinib was active against advanced non-small cell lung cancer (NSCLC) even in patients with poor performance status (PS). Clinical response among the patients harboring epidermal growth factor receptor (EGFR) mutation with poor PS is fair; however, gefitinib does n...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Okuma Y,Hosomi Y,Nagamata M,Yamada Y,Sekihara K,Kato K,Hishima T,Okamura T

    更新日期:2013-11-01 00:00:00

  • Cancer treatment-induced oral mucositis.

    abstract::Oral mucositis is one of the main complications in non-surgical cancer treatments. It represents the major dose-limiting toxicity for some chemotherapeutic agents, for radiotherapy of the head and neck region and for some radiochemotherapy combined treatments. Many reviews and clinical studies have been published in o...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Alterio D,Jereczek-Fossa BA,Fiore MR,Piperno G,Ansarin M,Orecchia R

    更新日期:2007-03-01 00:00:00

  • Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.

    abstract::We have recently identified ICBP90 as being a protein able to bind in vitro a CCAAT box of the topoisomerase II alpha gene promoter. The aim of the present work was to check whether ICBP90 is able to regulate in vivo topoisomerase II alpha expression in human lung fibroblasts under various proliferating conditions. Tr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hopfner R,Mousli M,Oudet P,Bronner C

    更新日期:2002-11-01 00:00:00

  • Partial characterization of protein tyrosine kinases in human lymphoid cells.

    abstract::We have examined several aspects of protein tyrosine kinase (PTK)-activity in the cytosolic and membrane fractions of both normal and malignant lymphoid cells. The expression of the PTK-encoding oncogenes fes, abl and src, was investigated with the use of antibodies generated to their respective gene products. These a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Punt CJ,Rijksen G,van Oirschot BA,Kester-Schipper GP,van der Heijden MC,Dekker AW,Staal GE

    更新日期:1992-11-01 00:00:00

  • Radiation-induced second malignancies.

    abstract:BACKGROUND:The number of patients with second malignancies is growing and they represent about one in six out of all new cancers. Second malignancies can be categorized into three major groups according to the predominant etiological factor(s): (i) treatment-related, (ii) part of a syndrome and (iii) those due to share...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Mahmood S,Vu K,Tai P,Joseph K,Koul R,Dubey A,Yu E

    更新日期:2015-04-01 00:00:00

  • Induction of tumor degeneration by sodium benzylideneascorbate.

    abstract::Intravenous administration of sodium benzylideneascorbate (SBA) rapidly necrotized inoperable human lung cancer, and induced degeneration of 3'-methyl-4-dimethylaminoazobenzene-induced rat hepatocellular carcinoma (vacuolar, eosinophilic degeneration, nuclear debris) without affecting the serum glutamic oxaloacetic tr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Sakagami H,Asano K,Fukuchi K,Gomi K,Ota H,Kazama K,Tanuma S,Kochi M

    更新日期:1991-07-01 00:00:00

  • Paracetamol counteracts docosahexaenoic acid-induced growth inhibition of A-427 lung carcinoma cells and enhances tumor cell proliferation in vitro.

    abstract::The belief that n-3 polyunsaturated fatty acids are in general cytotoxic to tumor cells appears not to be accurate. Of four tumor cell lines exposed to 35 microM docosahexaenoic acid (DHA, 22:6 n-3), we found only one (A-427, lung carcinoma) to be sensitive, whereas three (A-172, A549 and SK-LU-1) in fact were stimula...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schønberg SA,Skorpen F

    更新日期:1997-07-01 00:00:00

  • Prognostic role of angiogenesis in colorectal cancer.

    abstract::The need for dependable prognostic markers in colorectal cancer, both in the advanced as well the as adjuvant setting, is greater than ever. The introduction of new chemotherapeutic agents in the clinic, with different mechanisms of action as well as different side-effect profiles, has made this even more important. A...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Papamichael D

    更新日期:2001-11-01 00:00:00

  • Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector.

    abstract:BACKGROUND:E-selectin expression is very low in normal adult blood vessels, but is significantly elevated in newly formed tumor capillaries. We hypothesized that a viral vector which has transcriptional specificity for the tumor vasculature may be a tool for angiogenesis-targeted gene therapy. We therefore designed an ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Walton T,Wang JL,Ribas A,Barsky SH,Economou J,Nguyen M

    更新日期:1998-05-01 00:00:00

  • Presence of genetic alterations in microdissected stroma of human colon and breast cancers.

    abstract:BACKGROUND:Human carcinomas not only consist of neoplastic epithelial cells but also of tumor stroma, which may play an important role in tumor-progression. Whereas the tumor surrounding stroma is generally believed to represent a reactive component induced by tumor cell derived factors, a contribution of neoplastic ce...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wernert N,Löcherbach C,Wellmann A,Behrens P,Hügel A

    更新日期:2001-07-01 00:00:00